There are several signaling pathways that are known to be protagonists in the progression of leukemias, such as the PI3K/Akt/mTOR, Wnt/β-catenin, JAK/STAT, and NF-κB pathways [165,166,167,168]. Here, MTOR is linked to leukemia.